Search

Author/Creator van Vollenhoven, R. F.

1. Dysregulated Fcγ receptor IIa‐induced cytokine production in dendritic cells of lupus nephritis patients. (7th October 2019)

Authors:
Newling, M.; Fiechter, R. H.; Sritharan, L.; Hoepel, W.; van Burgsteden, J. A.; Hak, A. E.; van Vollenhoven, R. F.; van de Sande, M. G. H.; Baeten, D. L. P.; den Dunnen, J.
Journal:
Clinical and experimental immunology
Issue:
Volume 199:Number 1(2020)
Page Start:
39
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0060 A multi-biomarker disease activity blood test (vectra da) correlates with radiographic progression in early rheumatoid arthritis: results from the swefot trial. (23rd January 2014)

Authors:
Hambardzumyan, K.; Bolce, R.; Cavet, G.; Chernoff, D.; Haney, D.; Forslind, K.; Petersson, I.; Geborek, P.; Ernestam, S.; van Vollenhoven, R. F.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FRI0061 Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: results from the swefot trial. (23rd January 2014)

Authors:
Hambardzumyan, K.; Saevarsdottir, S.; Bolce, R.; Forslind, K.; Ernestam, S.; Petersson, I.; Geborek, P.; Chernoff, D.; Haney, D.; Sasso, E. H.; van Vollenhoven, R. F.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A388
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. OP0094 Cost-Effectiveness of Biologic Versus Conventional Combination Treatment in Early Rheumatoid Arthritis: 2-Year Results of the Randomised Controlled Swefot Trial. (23rd January 2014)

Authors:
Eriksson, J.; Karlsson, J. A.; Bratt, J.; Petersson, I. F.; van Vollenhoven, R. F.; Ernestam, S.; Geborek, P.; Neovius, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. SAT0006 No Differences in Patient-Reported Outcomes by Methotrexate Dose Among Early Rheumatoid Arthritis Patients Treated Concomitantly with Adalimumab: Results from the Concerto Trial. (23rd January 2014)

Authors:
Fleischmann, R. M.; Kivitz, A.; van Vollenhoven, R. F.; Shaw, J. W.; Florentinus, S.; Karunaratne, M.; Kupper, H.; Dougados, M.; Burmester, G.-R.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A580
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. SAT0131 Long-Term Safety of Rituximab: Pooled Analysis of the Rheumatoid Arthritis Global Clinical Trial Programme Over 11 Years. (23rd January 2014)

Authors:
van Vollenhoven, R. F.; Emery, P.; Bingham, C. O.; Keystone, E.; Fleischmann, R. M.; Furst, D.; Hessey, E. W.; Vashishtha, A.; Mehbob, A.; Lehane, P. B.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗